1. FRANK, SCOTT, ALAN,2. CHEN, XINCHAO,3. REMICK, DAVID MICHAEL,4. PEDERSEN, STEVEN WAYNE
申请号：
GT201100321
公开号：
GT201100321A
申请日:
2011.12.13
申请国别(地区):
GT
年份:
2012
代理人:
摘要：
1. The present invention is directed at [3,5-5-[[3,5-bis (trifluoromethyl) phenyl] methyl [2-meth-2H-tetrazol-5-il] amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-il] methylphenylpropylene oxide, which is used to treat cardiovascular diseases. It's on lipids and substances.LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS ACIDO TRANS-4-[[(5S)-5-[[[3,5-BIS (TRIFLUOROMETIL) FENIL] METIL] (2-METIL-2H-TETRAZOL-5-IL) AMINO] -2,3,4,5-TETRAHIDRO-7,9-DIMETIL-1H-1-BENZAZEPIN-1-IL] METIL] -CICLOHEXANCARBOXILICO CUYA UTILIDAD RADICA EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES TANTO EN CUADROS DISLIPIDÉMICOS COMO ATEROESCLEROSIS
